VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PENPenumbra, Inc.
$317.20$12.5B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPENPrice Target
PEN logo

Penumbra, Inc. (PEN) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Hold
Based on 22 analysts

16.1% Below Target

PEN trades 16.1% below Wall Street's consensus target of $368.18.

Current Price$317.20
Average Target$368.18
Target
Current
Low$335.00
Median$374.00
High$374.00

Analyst Target Range

Forward P/E64.4x
(High Premium)
PEG Ratio—
Implied Growth+13.9%
(Moderate)
Analyst Spread10.6%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$317.20
Consensus$368.18
High$374.00
Low$335.00

Consensus Scenario Assumptions

The base valuation assumes PEN achieves its forward estimates and maintains a stable P/E multiple of 64.4x. This scenario reflects the blended consensus of 22 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 22 published analyst recommendations for PEN

59% hold / mixed conviction
+20
BearishBullish
Weighted analyst sentiment score based on 22 ratings
ConsensusHold
Coverage22 Analysts
Net Score+20
Bull / Bear41% / 0%
Strong Buy00%
Buy941%
Hold1359%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
941%
Hold
1359%
Sell
00%
Strong Sell
00%
Recommendation Mix41% Buy · 59% Hold · 0% Sell
Buy (9)Hold (13)Sell (0)

PEN Price Target Analysis

Updated June 22, 2026

As of June 22, 2026, Penumbra, Inc. (PEN) has a Wall Street consensus price target of $368.18, based on estimates from 22 covering analysts. With the stock currently trading at $317.20, this represents a potential upside of +16.1%. The company has a market capitalization of $12.48B.

Analyst price targets range from a low of $335.00 to a high of $374.00, representing a 11% spread in expectations. The median target of $374.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Hold, with 9 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.

From a valuation perspective, PEN trades at a trailing P/E of 70.2x and forward P/E of 64.4x. Analysts expect EPS to grow +13.9% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $135.10, with bear and bull scenarios of $85.11 and $178.01 respectively. Model confidence stands at 58/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+48.0%
Industry Consensus
Avg Forward P/E
102.0x
(High Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
ISRG logo
ISRGIntuitive Surgical, Inc.
$144.5B$406.78$597.78
+47.0%
Buy38.9x55
NVCR logo
NVCRNovoCure Limited
$1.6B$14.28$33.00
+131.1%
Buy—15
NVST logo
NVSTEnvista Holdings Corp
$4.2B$25.91$28.33
+9.3%
Hold18.1x19
INVA logo
INVAInnoviva, Inc.
$1.7B$22.49$37.00
+64.5%
Buy6.3x10
SYK logo
SYKStryker Corporation
$117.9B$307.80$387.46
+25.9%
Buy20.5x51
BSX logo
BSXBoston Scientific Corporation
$67.3B$45.29$82.90
+83.0%
Buy13.5x44
MDT logo
MDTMedtronic plc
$101.9B$79.34$95.80
+20.7%
Buy13.3x51
EW logo
EWEdwards Lifesciences Corporation
$50.4B$87.36$96.55
+10.5%
Buy29.0x48
ATRC logo
ATRCAtriCure, Inc.
$1.5B$28.80$51.33
+78.2%
Buy768.0x19
ZBH logo
ZBHZimmer Biomet Holdings, Inc.
$17.2B$87.97$96.33
+9.5%
Hold10.4x42

PEN — Frequently Asked Questions

Quick answers to the most common questions about buying PEN stock.

What is the PEN stock price target for 2026?

Penumbra, Inc. (PEN) has a consensus 12-month price target of $368.18, implying 16.1% upside from $317.2. The 22 analysts covering PEN see moderate appreciation potential.

Is PEN a buy, sell, or hold?

PEN has a consensus rating of "Hold" based on 22 Wall Street analysts. The rating breakdown is mixed, with 13 Hold ratings making up the largest segment. The consensus 12-month price target of $368.18 implies 16.1% upside from current levels.

Is PEN stock overvalued or undervalued?

At a forward P/E of 64.3982x, PEN trades at a premium valuation. The consensus price target of $368.18 (16.1% upside) suggests analysts still see growth justifying the multiple.

How high can PEN stock go?

The most bullish Wall Street analyst has a price target of $374 for PEN, while the most conservative target is $335. The consensus of $368.18 represents the median expectation. Our quantitative valuation model projects a bull case target of $178 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover PEN stock?

PEN is well covered by analysts, with 22 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 13 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the PEN stock forecast?

The 12-month PEN stock forecast based on 22 Wall Street analysts shows a consensus price target of $368.18, with estimates ranging from $335 (bear case) to $374 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $135, with bear/bull scenarios of $85/$178.

What is PEN's fair value based on fundamentals?

Our quantitative valuation model calculates PEN's fair value at $135 (base case), with a bear case of $85 and bull case of $178. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 58/100.

What is PEN's forward P/E ratio?

PEN trades at a forward P/E ratio of 64.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 70.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy PEN stock?

Wall Street analysts are optimistic on PEN, with a "Hold" consensus rating and $368.18 price target (16.1% upside). 9 of 22 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do PEN price targets vary so much?

PEN analyst price targets range from $335 to $374, a 11% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $368.18 consensus represents the middle ground. Our model's $85-$178 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into PEN consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare